AHA Comments on Medicare Advantage Proposed Rule for Contract Years 2021 and 2022

The American Hospital Association appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services’ proposed regulation regarding policy and technical changes to Medicare Advantage and Part D prescription drug program for Contract Years 2021 and 2022. The proposed rule addresses a number of areas of importance to hospitals and health systems, including those that sponsor MA plans.

The AHA supports CMS’s efforts to provide plans with additional flexibilities to facilitate innovation under the MA program to meet the unique and complex needs of the Medicare population. We, however, have concerns regarding several proposals addressing network adequacy in the proposed rule.

Related Resources

AHA Center for Health Innovation Market Scan
Member
Disruption just keeps coming in the primary care sector. Denver-based startup Everside Health Group, which offers a nationwide in-person and virtual primary…
AHA Center for Health Innovation Market Scan
During the height of the pandemic, McKinsey…
AHA Center for Health Innovation Market Scan
Remote patient monitoring (RPM) got a huge lift during the pandemic as record numbers of Americans opted for connected care from the safety of their homes, but…
Letter/Comment
Public
The AHA expresses support for the Protecting Rural Telehealth Access Act (S. 1988),
AHA Center for Health Innovation Market Scan
When it comes to telehealth, convenience appears to be king, according to the HIMSS 2021 State of Healthcare Report. Nearly two-thirds of patients surveyed in…
AHA Center for Health Innovation Market Scan
Amazon is pursuing an aggressive strategy to rapidly scale its telehealth service, known as Amazon Care, not only to all its employees but to other employers.…